Healthequity (HQY) Downgraded by BidaskClub to Buy
BidaskClub lowered shares of Healthequity (NASDAQ:HQY) from a strong-buy rating to a buy rating in a research note released on Tuesday morning.
HQY has been the subject of several other reports. Bank of America lowered shares of Healthequity from a buy rating to a neutral rating and increased their target price for the stock from $84.00 to $105.00 in a report on Thursday, September 6th. They noted that the move was a valuation call. SunTrust Banks increased their target price on shares of Healthequity to $105.00 and gave the stock a buy rating in a report on Wednesday, September 5th. Wells Fargo & Co increased their target price on shares of Healthequity from $84.00 to $105.00 and gave the stock an outperform rating in a report on Wednesday, September 5th. Zacks Investment Research raised shares of Healthequity from a sell rating to a hold rating in a report on Friday, July 20th. Finally, Barrington Research reissued an outperform rating and issued a $100.00 target price on shares of Healthequity in a report on Wednesday, September 5th. They noted that the move was a valuation call. Four equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of Buy and a consensus target price of $93.08.
NASDAQ HQY opened at $83.48 on Tuesday. Healthequity has a 52 week low of $42.92 and a 52 week high of $99.99. The stock has a market cap of $5.86 billion, a PE ratio of 154.59, a price-to-earnings-growth ratio of 3.28 and a beta of 1.47.
In other Healthequity news, VP Darcy G. Mott sold 4,000 shares of the company’s stock in a transaction that occurred on Thursday, September 20th. The stock was sold at an average price of $92.93, for a total value of $371,720.00. Following the completion of the transaction, the vice president now directly owns 96,100 shares in the company, valued at approximately $8,930,573. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 4.00% of the company’s stock.
A number of hedge funds have recently bought and sold shares of the business. Cerebellum GP LLC bought a new position in Healthequity in the 3rd quarter worth approximately $185,000. Jaffetilchin Investment Partners LLC bought a new position in Healthequity in the 3rd quarter worth approximately $235,000. Barometer Capital Management Inc. bought a new position in Healthequity in the 3rd quarter worth approximately $8,166,000. United Services Automobile Association boosted its stake in Healthequity by 7.1% in the 2nd quarter. United Services Automobile Association now owns 8,298 shares of the company’s stock worth $623,000 after purchasing an additional 548 shares during the period. Finally, Northern Trust Corp boosted its stake in Healthequity by 4.6% in the 2nd quarter. Northern Trust Corp now owns 694,666 shares of the company’s stock worth $52,169,000 after purchasing an additional 30,581 shares during the period. Institutional investors and hedge funds own 96.94% of the company’s stock.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Story: Stock Split
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.